Shkreli a Symptom of What’s Wrong with Pharma Industry
Shkreli is Wrong, But Only Responding to Government Incentives by Ben Ramanauskas Martin Shkreli has managed to engender feelings of revulsion in the vast majority of the population. He incurred widespread odium when his company, Turing Pharmaceuticals, acquired the drug Daraprim, which is commonly used to treat toxoplasmosis, which kills people with weakened immune systems, such…

